blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1532276

EP1532276 - DIAGNOSTIC AND THERAPEUTIC USE OF FOAP-13 POLYNUCLEOTIDES AND POLYPEPTIDES FOR NEURODEGENERATIVE DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.10.2009
Database last updated on 12.11.2024
Most recent event   Tooltip30.10.2009Application deemed to be withdrawnpublished on 02.12.2009  [2009/49]
Applicant(s)For all designated states
EVOTEC Neurosciences GmbH
Schnackenburgallee 114
22525 Hamburg / DE
[2005/21]
Inventor(s)01 / VON DER KAMMER, Heinz
Verbindungsstrasse 6d
22607 Hamburg / DE
02 / POHLNER, Johannes
Quittenweg 11
22175 Hamburg / DE
 [2005/21]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2005/21]von Kreisler Selting Werner
Patentanwälte P.O. Box 10 22 41
50462 Köln / DE
Application number, filing date03790923.126.08.2003
[2005/21]
WO2003EP09437
Priority number, dateEP2002001928128.08.2002         Original published format: EP 02019281
US20020406303P28.08.2002         Original published format: US 406303 P
[2005/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004020665
Date:11.03.2004
Language:EN
[2004/11]
Type: A2 Application without search report 
No.:EP1532276
Date:25.05.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.2004 takes the place of the publication of the European patent application.
[2005/21]
Search report(s)International search report - published on:EP02.09.2004
ClassificationIPC:C12Q1/68, C12N9/10, G01N33/53, A01K67/027, A61P25/00
[2005/21]
CPC:
G01N33/6896 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
C12Q1/6883 (EP,US); C12Q2600/158 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/21]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:DIAGNOSTISCHE UND THERAPEUTISCHE VERWENDUNG VON FOAP-13 POLYNUKLEOTIDEN UND POLYPEPTIDEN FÜR NEURODEGENERATIVE ERKRANKUNGEN[2005/21]
English:DIAGNOSTIC AND THERAPEUTIC USE OF FOAP-13 POLYNUCLEOTIDES AND POLYPEPTIDES FOR NEURODEGENERATIVE DISEASES[2005/21]
French:UTILISATION DE POLYNUCLEOTIDES ET DE POLYPEPTIDES DU GENE FOAP-13 POUR LE DIAGNOSTIC ET LA THERAPIE DE MALADIES NEURODEGENERATIVES[2005/21]
Entry into regional phase22.02.2005National basic fee paid 
22.02.2005Designation fee(s) paid 
22.02.2005Examination fee paid 
Examination procedure22.03.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.02.2005Examination requested  [2005/21]
26.01.2009Despatch of a communication from the examining division (Time limit: M04)
06.06.2009Application deemed to be withdrawn, date of legal effect  [2009/49]
14.07.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/49]
Fees paidRenewal fee
18.08.2005Renewal fee patent year 03
29.08.2006Renewal fee patent year 04
29.08.2007Renewal fee patent year 05
28.03.2008Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.200907   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0149879  (AROS APPLIED BIOTECHNOLOGY APS [DK], et al) [X] 3,10-13 * See page 21, page 25 (PRO1659) and page 57; claims 27-25. *;
 WO0153312  [ ] (HYSEQ INC [US], et al) [ ] * page 1 - page 98; claims 1-28 *;
 WO0112662  [ ] (INCYTE GENOMICS INC [US], et al) [ ] * the whole document *;
 [A]EP1188839  (EVOTEC NEUROSCIENCES GMBH [DE]) [A] * the whole document *;
 [A]WO0216636  (EVOTEC NEUROSCIENCES GMBH [DE], et al) [A] * the whole document *;
 [X]  - GENESEQ, EBI, (20011022), Database accession no. AAM38716, XP002269445 [X] 3,5,10-13 * abstract *
 [X]  - LAL ET AL., "Human membrane associated protein MEMAP-12", GENESEQ, EBI, Database accession no. AAB74706, XP002270793 [X] 3,5,10-13 * abstract *
 [X]  - STUART R O ET AL, "EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis.", AMERICAN JOURNAL OF PHYSIOLOGY. RENAL PHYSIOLOGY. UNITED STATES DEC 2001, (200112), vol. 281, no. 6, ISSN 0363-6127, pages F1148 - F1156, XP002247125 [X] 3,10,11 * the whole document *
 [X]  - Database accession no. Q9NSS4, URL: SWALL, XP002247127 [X] 10,11 * abstract *
 [A]  - LORING J F ET AL, "A gene expression profile of Alzheimer's disease.", DNA AND CELL BIOLOGY. UNITED STATES NOV 2001, (200111), vol. 20, no. 11, ISSN 1044-5498, pages 683 - 695, XP002233087 [A] * the whole document *

DOI:   http://dx.doi.org/10.1089/10445490152717541
 [A]  - "Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.", NEUROBIOLOGY OF AGING. UNITED STATES 1998 MAR-APR, (199803), vol. 19, no. 2, ISSN 0197-4580, pages 109 - 116, XP002233088 [A] * the whole document *

DOI:   http://dx.doi.org/10.1016/S0197-4580(98)00022-0
 [A]  - LI M S ET AL, "Human eosinophil major basic protein, a mediator of allergic inflammation, is expressed by alternative splicing from two promoters.", THE BIOCHEMICAL JOURNAL. ENGLAND 1 FEB 1995, (19950201), vol. 305 ( Pt 3), ISSN 0264-6021, pages 921 - 927, XP002057386 [A] * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.